市場調査レポート
商品コード
1045915
小児用ワクチンの世界市場 - シェア・予測 (2022年~2027年) :業界動向、成長、規模、COVID-19の影響、企業分析Pediatric Vaccines Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis |
小児用ワクチンの世界市場 - シェア・予測 (2022年~2027年) :業界動向、成長、規模、COVID-19の影響、企業分析 |
出版日: 2022年01月01日
発行: Renub Research
ページ情報: 英文 150 Pages
納期: 即日から翌営業日
|
世界の小児用ワクチンの市場規模は、2021年の478億米ドルから、2027年までに620億米ドルに達し、2021年~2027年のCAGRで4.4%の成長が予測されています。世界の小児用ワクチン市場は堅調で、莫大な可能性に到達することに成功しています。
当レポートでは、世界の小児用ワクチン市場について調査分析し、業界動向、成長、規模、COVID-19の影響、主要企業などについて、体系的な情報を提供しています。
Global Pediatric Vaccines Market is expected to reach USD 62 Billion in 2027. In this huge market of vaccines Pediatric Vaccines for Coronavirus account for a significant market share. Over the years, Pediatric vaccination has made a tremendous public health success story. The lives of billions of children have been saved, and millions have the chance of a longer, healthier life, a more significant opportunity to learn, play, read and write, and move around freely without suffering. Besides, in the 21st century, the development, licensing, and implementation of Pediatric vaccines as part of large, systematic immunization programs have also addressed global health inequities. Therefore, imagining a world without vaccines would be life-threatening, with diseases presenting daily risk.
With the emergence of the SARS-CoV-2 virus in December 2019 and its potential for global dissemination to cause COVID-19 disease was realized, there was an urgent need to develop vaccines at an unprecedented rate and scale for the particular pandemic. Hence, amidst the pandemic, the global market for Pediatric vaccines declined in 2020 as most of the healthcares personal were busy in COVID-19 management.
However, the Pediatric vaccines market size has shown tremendous growth for the year 2021. All thanks to the COVID-19 vaccines approval for children in few western countries. Furthermore, as we appreciate and quantify the health, economic and social benefits of Pediatric vaccines and immunization programs to individuals and society. We endeavour to see the Global Pediatric Vaccine Industry to register a CAGR of 4.4% during the forecast period of 2021-2027.
At the same time, access to Pediatric vaccines that prevent life-threatening infectious diseases remains variable to all infants around the world. Further, to eradicate such problems, numerous individuals and agencies are working hard to address them globally. Recently, the development of safe and efficacious vaccination against diseases that cause substantial morbidity and mortality has been a significant scientific advance. Vaccination, sanitation, and clean drinking water are public health interventions that are undeniably responsible for improved infant health outcomes globally.
For instance, agencies including the United Nations Children's Fund (UNICEF), World Health Organization (WHO), Gavi, The Bill & Melinda Gates Foundation, the Vaccine Alliance, and the Coalition for Epidemic Preparedness Initiative (CEPI), with their multiple funding streams have been instrumental in expanding vaccine benefits to all.
The global pediatric vaccines market is robust and has successfully reached enormous potential. Hence, pediatric vaccines are among tremendous advances in global health and development. Besides, pediatric vaccines have safely reduced the scourge of diseases like Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTaP, Hib (Haemophilus Influenza Type B), Combos (Combination Vaccines), Polio, Rotavirus and Varicella, helping children grow up healthy and happy. Remarkably, with immunization efforts worldwide, children can walk, play, dance and learn. Today, vaccines are expected to be one of the most cost-effective means of advancing global welfare.
The Pediatric vaccines market consists of several major players, including GlaxoSmithKline, Merck & Co, Sanofi Pasteur's, Pfizer, Inc. and Thoracic Aortic Aneurysm (TAA)CSL Limited. Notwithstanding, the key players of pediatric vaccines are broad and far-reaching, though not consistently quantifiable, analyzed or communicated. However, an increasing appreciation for vaccines' economic and social effects is being included in the development of the new vaccine, potentially realizing a more significant benefit to society and resulting in broader implementation by the companies.
Renub Research latest report "Pediatric Vaccines Market, Global Forecast By Disease Wise (Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTaP, Hib (Haemophilus Influenza Type B), Combos (Combination Vaccines), Polio, Rotavirus and Varicella), Crop (Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTaP, Hib (Haemophilus Influenza Type B), Combos (Combination Vaccines), Polio, Rotavirus and Varicella), Products and Pipeline (GSK Vaccine Product Pipeline, Merck Vaccine Product Pipeline, Sanofi Vaccine Product Pipeline and Pfizer Vaccine Product Pipeline), Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa), Key Players Sales (GlaxoSmithKline, Merck & Co, Sanofi Pasteur's, Pfizer, Inc. and Thoracic Aortic Aneurysm (TAA)CSL Limited)" provides a detailed analysis of Pediatric Vaccines Industry.